Dr Neil Rabin, Consultant Haematologist
Dr Neil Rabin
Consultant Haematologist
Dr Neil Rabin MBBS, PhD, MRCP (UK), FRCPath
Consultant Haematologist
Dr Neil Rabin
Consultant Haematologist MBBS, PhD, MRCP (UK), FRCPath
Dr Rabin is a Consultant Haematologist
Areas of expertise
- Blood diseases (clinical haematology)
- Myeloma
- Haematological oncology
- Blood cancer
- Bone marrow transplant
Make an appointment
Address
-
HCA UK at University College Hospital
Grafton Way Building, 1 Grafton Way, London, WC1E 6AG
About Dr Neil Rabin
GMC number: 4306061
Year qualified: 1996
Place of primary qualification: University of London
Dr Neil Rabin is a consultant haematologist at University College Hospital. He has been serving in this role since his appointment in 2010. Dr Rabin specialises in haematology with a particular focus on myeloma. His areas of expertise include clinical trials evaluating new treatments for myeloma both at diagnosis and at relapse.
Dr Rabin is deeply involved in the advancement of medical research and is committed to improving patient outcomes through innovative treatment options. He is passionate about exploring new therapies and their potential benefits for patients suffering from myeloma.
In his role at University College Hospital, Dr Rabin is responsible for overseeing clinical trials, managing patient care, and collaborating with a multidisciplinary team to ensure comprehensive treatment plans. His dedication to his field is evident in his continuous efforts to stay at the forefront of haematological research and treatment.
Dr Rabin's professional interests extend beyond clinical trials. He is also involved in educating future medical professionals and contributing to the broader medical community through his research and publications.
Patients under Dr Rabin's care can expect a thorough and compassionate approach to their treatment, with a strong emphasis on the latest advancements in haematology. His commitment to excellence and patient-centred care makes him a highly respected figure in his field.
Areas of expertise
- Thrombosis and embolism
- Lymphomas
- Bleeding disorders
Professional memberships
Articles by Dr Neil Rabin
Real‐world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (covid‐19 disease) in patients with multiple myeloma receiving systemic anti‐cancer therapy.
Fatigue, quality of life and physical fitness following an exercise intervention in multiple myeloma survivors (mascot): an exploratory randomised phase 2 trial utilising a modified zelen design
Spinal disease in myeloma: cohort analysis at a specialist spinal surgery centre indicates benefit of early surgical augmentation or bracing - additional file 1
Whole body magnetic resonance imaging in newly diagnosed multiple myeloma: early changes in lesional signal fat fraction predict disease response
A new prognostic model for myeloma patients relapsing from upfront autologous transplantation based on iss and pfs1
